At the European Association for the Study of Diabetes meeting, Louis J. Aronne, MD, argued that obesity medications could make bariatric surgery obsolete, thanks to drugs that treat multiple metabolic conditions. Francesco Rubino, MD, countered, suggesting “metabolic” surgery will continue to play a key role, especially for long-term management of obesity and related conditions. Aronne believes future treatments will address obesity earlier, while Rubino sees surgery remaining important for certain patients. Both agree obesity management is evolving rapidly.
Trending
- Exploring Exhaled Breath as a New Platform for Gut Microbiome-Based Diagnostics (HCP Live)
- The Medical Futurist’s 100 Digital Health And AI Companies Of 2026 (The Medical Futurist)
- MedPAC signals need to bolster Medicare physician payments (American Medical Association)
- Want to Reach Nirvana? Try a Colonoscopy. (The New York Times)
- Aidoc Secures FDA Clearance for Healthcare’s First Comprehensive Foundation Model AI (AIdoc)
- NYU Langone Health Announces Gastrointestinal Cancer & Translational Research Leader Dr. Anirban Maitra as New Director of Perlmutter Cancer Center (NYU Langone Health)
- Bringing biomarker testing within reach: CLEAR for CRC to empower patients from day one (Colorectal Cancer Alliance)
- GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test (GRAIL)
